New CAR-T therapy aims to tackle tough lymphoma
NCT ID NCT07360288
First seen Jan 29, 2026 · Last updated May 14, 2026 · Updated 10 times
Summary
This study tests a new treatment called TC011, which uses a patient's own immune cells modified to attack lymphoma cells. It is for adults with follicular lymphoma that has returned or not responded to at least two prior therapies. The main goal is to see how many patients' tumors shrink or disappear after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOLLICULAR LYMPHOMA (FL) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.